Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Study of Single and Repeat Dose Administration of UBX0101 in Patients With Osteoarthritis of the Knee

ClinicalTrials.gov ID: NCT04229225

Public ClinicalTrials.gov record NCT04229225. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 2, 2026, 9:00 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo-Controlled Study of Single and Repeat Dose Administration of UBX0101 in Moderate to Severe, Painful Osteoarthritis of the Knee

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A study to assess safety, tolerability and clinical effects of single and repeat dose intra-articular administration of UBX0101 in patients with moderate to severe painful knee osteoarthritis (OA).

Study identification

NCT ID
NCT04229225
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Unity Biotechnology, Inc.
Industry
Enrollment
35 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
40 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 23, 2020 (Actual)
Primary completion
Sep 18, 2020 (Actual)
Completion
Sep 18, 2020 (Actual)
Last update posted
Oct 19, 2020

2020

United States locations

U.S. sites
7
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
Premier Medical Associates The Villages Florida 32159 —
Drug Studies America Marietta Georgia 30060 —
Sundance Clinical Research, LLC St Louis Missouri 63141 —
Hassman Research Institute Berlin New Jersey 08009 —
Rochester Clinical Research, Inc. Rochester New York 14609 —
Arcis Healthcare LLC dba Lowcountry Orthopaedics and Sports Medicine North Charleston South Carolina 29406 —
First Surgical Hospital Bellaire Texas 77401 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04229225, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 19, 2020 · Synced Nov 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04229225 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →